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INTRODUCTION
Mouse embryonic stem (mES) cell pro-
liferation depends exclusively on the
nutritionally essential amino acid, L-
threonine, in the medium. Other essential
and non-essential amino acids need
not be added to the medium for mES
cell proliferation. Furthermore, the
threonine analog, 3-hydroxynorvaline
(3-HNV), selectively inhibits mES cell
proliferation (Wang et al., 2009). HeLa,
MEF and 3T3 cell growth all are not
affected by 3-HNV. Selective inhibi-
tion of ES cell proliferation by 3-HNV
is expected to have teratogenic and
embryotoxic effects on development,
and these effects have been observed in
chicken and mouse embryos (Louw et al.,
2005).
It has been proposed that rapid
catabolism via threonine dehydrogenase
(TDH) accounts for how threonine sup-
plementation is needed to support mES
cell proliferation and that TDH is the site
of 3-HNV inhibition of mES cell prolifer-
ation (Wang et al., 2009; Han et al., 2013;
Chen and Wang, 2014). In support of
this possibility, TDH induction enhances
reprogramming of mouse somatic cells
into induced pluripotent stem (iPS) cells,
and 3-HNV inhibits this induction (Han
et al., 2013). The concentrations of thre-
onine or 3-HNV needed for mES cell
proliferation or its inhibition are, how-
ever, over an order of magnitude lower
than the apparent Km or Ki values for
interaction of threonine or 3-HNV with
TDH (Wang et al., 2009). Hence, another
mechanism may account for the influ-
ences of threonine and 3-HNV on mES
cell proliferation. To test this hypothesis,
we determined whether 3-HNV inhibits
human embryonic stem (hES) cell prolif-
eration. Humans produce truncated and
apparently inactive TDH proteins that
cannot make appropriate contact with 3-
HNV, threonine or NAD+, the cofactor
needed for TDH activity (Edgar, 2002).
MATERIALS AND METHODS
hES cells (H9 cell line, WA09) were
maintained in complete Stem-Pro
medium, DMEM/F12, supplemented
with GlutaMax,™ Stem Pro®Supplement,
Bovine Serum Albumin, FGF, and
2,β-Mercapthneol; the medium was
changed daily. Human ES cells were cul-
tured for 3 days prior to removal of
medium and addition of experimental
culture media. ES cells were cultured with-
out mouse feeder cells. The diameters of
all colonies were measured daily for 3 days
using an inverted microscope. Each treat-
ment group included at least six colonies
in each of three independent experiments
(total of at least 18 colonies in each group).
The mean colony diameters of each of the
four groups indicated in Figure 1 were
compared statistically using analysis of
variance (except the 3-HNV treatment
group on day 3).
RESULTS AND DISCUSSION
The diameters of all colonies were mea-
sured daily for 3 days using an inverted
microscope (except the 3-HNV treatment
group on day 3). Four mM 3-HNV
inhibited growth of hES cell colonies
over the first 2 days of treatment (p <
0.0001). Moreover, hES cell colonies lost
integrity and dissociated after 3 days
of treatment with 4.0mM 3-HNV. All
such colonies appeared to be dead. Four
mM L-threonine largely rescued hES cells
from 3-HNV inhibition (p < 0.0001) and
apparent toxicity. This threonine rescue
from 3-HNV included elongation and
apparent differentiation of a greater pro-
portion of rescued hES cells relative to
control hES cells, so the rescue was likely
incomplete (e.g., Figure 1). Nevertheless,
TDH cannot be the site of 3-HNV action
in hES cells nor can it account for the
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FIGURE 1 | hES cell and colony morphology after 2 days of culture in complete Stem-Pro
medium (control) or this medium containing 4.0mM L-threonine, 3-HNV or both 3-HNV
and L-threonine. Threonine (4.0mM) rescued hES cells from 4.0mM 3-HNV. (Scale bar = 50 um)
ability of threonine to rescue hES cells
from 3-HNV. These observations open the
question whether TDH is the only site of
action of 3-HNV and threonine in mES
cells. In this regard, threonine regulates the
G1/S phase transition in mES cells in part
through interaction with an amino acid
transport system in the plasma membrane
of the cells (Ryu and Han, 2011).
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